Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | PDE5A | O76074 | 4/20 | 0.44 |
| ▸ | AURKA | O14965 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.43 |
| ▸ | TERT | O14746 | 2/20 | 0.43 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28470344 | 0.98 | ALDH1A1 (0.49) | ALDH1A1HPGDSMN1; SMN2KDM4EMEN1 | |
| SCHEMBL28478662 | 0.98 | ALDH1A1 (0.49) | ALDH1A1HPGDSMN1; SMN2KDM4EMEN1 | |
| SCHEMBL28484510 | 0.98 | ALDH1A1 (0.49) | ALDH1A1HPGDSMN1; SMN2KDM4EMEN1 | |
| SCHEMBL28469387 | 0.98 | ALDH1A1 (0.49) | ALDH1A1HPGDSMN1; SMN2KDM4EMEN1 | |
| SCHEMBL12563101 | 0.93 | ALDH1A1 (0.44) | ALDH1A1HPGDSMN1; SMN2KDM4EMEN1 | |
| SCHEMBL9365644 | 0.86 | FGFR1 (0.41) | ALDH1A1HPGDSMN1; SMN2KDM4EMEN1 | |
| SCHEMBL9581910 | 0.83 | TERT (0.45) | TERT | |
| SCHEMBL29408466 | 0.83 | TERT (0.45) | TERT | |
| SCHEMBL11894485 | 0.83 | CA1 (0.41) | MAPTTERT | |
| SCHEMBL9366429 | 0.83 | MAP2 (0.44) | PDE5ATERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0804732-B1 | A BIOSPECIFIC MULTIPARAMETER ASSAY METHOD | SOINI ERKKI (FI) | 2001-10-10 | — | — | EP | claimed |
| US-5891738-A | USING MICROPARTICLES COATED WITH REACTANT AND CONTAINING FLUORESCENT INDICATOR, SECONDARY REACTANTS LABELLED WITH PHOTOLUMINESCENT LABEL, ACTIVATING, MEASURING PHOTON EMISSION | Soini, Erkki (FI) | 1999-04-06 | — | — | US | claimed |
| EP-0804732-A1 | A BIOSPECIFIC MULTIPARAMETER ASSAY METHOD | SOINI, Erkki (FI) | 1997-11-05 | — | — | EP | claimed |
| WO-1996022531-A1 | A BIOSPECIFIC MULTIPARAMETER ASSAY METHOD | SOINI ERKKI (FI) | 1996-07-25 | — | — | WO | claimed |
| US-5204215-A | Wavelength multiplexed optical recording material | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1993-04-20 | — | — | US | claimed |
| US-10662211-B2 | Catalysts and methods for polymer synthesis | Saurdi Aramco Technologies Company (SA) | 2020-05-26 | — | — | US | disclosed |
| US-20180179242-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | NOVOMER, INC. | 2018-06-28 | — | — | US | disclosed |
| US-9951096-B2 | Catalysts and methods for polymer synthesis | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2018-04-24 | — | — | US | disclosed |
| US-9793587-B2 | Electrode material, electrode, and battery | SONY CORPORATION (JP) | 2017-10-17 | — | — | US | disclosed |
| US-20170235034-A1 | PHOTO-STABLE AND THERMALLY-STABLE DYE COMPOUNDS FOR SELECTIVE BLUE LIGHT FILTERED OPTIC | FRONTIER SCIENTIFIC, INC. (US) | 2017-08-17 | — | — | US | disclosed |
| US-20170237135-A1 | ELECTRODE MATERIAL, ELECTRODE, AND BATTERY | MURATA MANUFACTURING CO., LTD. (JP) | 2017-08-17 | — | — | US | disclosed |
| US-20170183369-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2017-06-29 | — | — | US | disclosed |
| WO-1996022531-A1 | A BIOSPECIFIC MULTIPARAMETER ASSAY METHOD | SOINI ERKKI (FI) | 1996-07-25 | — | — | WO | disclosed |
| EP-0451650-B1 | Method for the production of o-hydroxy-benzaldehydes | BAYER AG (DE) | 1994-08-24 | — | — | EP | disclosed |
| US-5130493-A | Oxidation of o-cresol in the presence of a chelate compound of iron and manganese with mesotetraarylporphine | BAYER AKTIENGESELLSCHAFT (DE) | 1992-07-14 | — | — | US | disclosed |
| EP-0451650-A1 | Method for the production of o-hydroxy-benzaldehydes | BAYER AG (DE) | 1991-10-16 | — | — | EP | disclosed |
| US-4837221-A | ADMINISTERING PORPHYRIN DERIVATIVE TO LOCATE TUMOR, ILLUMINATING WITH LIGHT | EFAMOL LTD. (GB) | 1989-06-06 | — | — | US | disclosed |
| EP-0186962-A1 | Porphyrins and cancer treatment | EFAMOL LIMITED (GB) | 1986-07-09 | — | — | EP | disclosed |
| US-4256597-A | DETERGENT AND PHOTOINITIATOR COMPRISING A PORPHINE OR MONO, DI, OR TRIAZO PORPHINE, OR PHTHALOCYANINE COMPOUND; WATER SOLUBILITY; STAIN REMOVAL | THE PROCTER & GAMBLE COMPANY (US) | 1981-03-17 | — | — | US | disclosed |
| EP-0003149-A2 | Composition containing a photoactivator for improved washing and bleaching of fabrics | THE PROCTER & GAMBLE COMPANY (US) | 1979-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662211-B2 | Catalysts and methods for polymer synthesis | PPOX, COASY, SOD1 | ALDH1A1 2255/4885HPGD 143/4885SMN1; SMN2 4314/4885 |
| US-20180179242-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | PPOX, COASY, SOD1 | ALDH1A1 2255/4885HPGD 143/4885SMN1; SMN2 4314/4885 |
| US-20170183369-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | PPOX, COASY, SOD1 | ALDH1A1 2255/4885HPGD 143/4885SMN1; SMN2 4314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.